All data are based on the daily closing price as of January 23, 2025
h
Hisamitsu Pharmaceutical
4530.TSE
29.66 USD
0.02
+0.07%
Overview
Last close
29.66 usd
Market cap
2.18B usd
52 week high
36.63 usd
52 week low
22.74 usd
Target price
28.76 usd
Valuation
P/E
21.782
Forward P/E
N/A
Price/Sales
2.2558
Price/Book Value
1.296
Enterprise Value
1.43B usd
EV/Revenue
1.486
EV/EBITDA
10.1594
Key financials
Revenue TTM
959.89M usd
Gross Profit TTM
447.83M usd
EBITDA TTM
124.42M usd
Earnings per Share
1.25 usd
Dividend
0.82 usd
Total assets
2.40B usd
Net debt
-769.29M usd
About
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.